U
CaliPharms, Inc. KGET
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2014 06/30/2014
Revenue 81.82% 68.37%
Total Other Revenue -- --
Total Revenue 81.82% 68.37%
Cost of Revenue 32.68% 104.84%
Gross Profit 58.66% -237.74%
SG&A Expenses 38.33% -50.74%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 36.98% -39.85%
Operating Income -28.74% 46.17%
Income Before Tax -218.95% -67.35%
Income Tax Expenses -- --
Earnings from Continuing Operations -218.95% -67.35%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -218.95% -67.35%
EBIT -28.74% 46.17%
EBITDA -- --
EPS Basic -200.00% -33.33%
Normalized Basic EPS -300.00% 0.00%
EPS Diluted -200.00% -33.33%
Normalized Diluted EPS -300.00% 0.00%
Average Basic Shares Outstanding 9.24% 1.02%
Average Diluted Shares Outstanding 9.24% 1.02%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings